Lowering health risks through product innovation
We develop innovative nicotine delivery systems that reduce risk, provide a satisfying user experience, and redefine expectations in a competitive market.
Smoking remains a leading cause of preventable deaths worldwide. Tobacco harm reduction (THR) presents an opportunity to address this global health challenge, shifting millions of consumers toward lower-risk alternatives. To capitalise on this opportunity, THR markets require advanced innovation to deliver a satisfying user and brand experience which also addresses growing regulatory and sustainability requirements.
We meet this challenge with a world-class team of researchers, scientists, designers, and engineers who have been developing commercially successful THR products since the category emerged. Our experience and expertise rival any in the world. Over the years, we’ve developed sophisticated nicotine-yielding product testing facilities and a deep knowledge of aerosol generation, underpinned by our work on medical devices. Our unparalleled experience supports clients in their product stewardship: selecting materials, testing for safety, quality, user experience, and navigating the increasingly complex regulatory landscape.
Our multi-disciplinary team approaches THR projects with an evidence-based understanding of unmet user needs which we use to align our innovation process with broad stakeholder requirements. This translates to commercial success for our clients, a positive impact on public health and millions of lives improved by the power of innovation.
